IRIS Accounts Production v25.4.0.155 08250302 director 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh082503022024-03-31082503022025-03-31082503022024-04-012025-03-31082503022023-03-31082503022023-04-012024-03-31082503022024-03-3108250302ns15:EnglandWales2024-04-012025-03-3108250302ns14:PoundSterling2024-04-012025-03-3108250302ns10:Director12024-04-012025-03-3108250302ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3108250302ns10:SmallEntities2024-04-012025-03-3108250302ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3108250302ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3108250302ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3108250302ns10:FullAccounts2024-04-012025-03-3108250302ns10:RegisteredOffice2024-04-012025-03-3108250302ns5:CurrentFinancialInstruments2025-03-3108250302ns5:CurrentFinancialInstruments2024-03-3108250302ns5:ShareCapital2025-03-3108250302ns5:ShareCapital2024-03-3108250302ns5:RetainedEarningsAccumulatedLosses2025-03-3108250302ns5:RetainedEarningsAccumulatedLosses2024-03-3108250302ns5:FurnitureFittings2024-04-012025-03-3108250302ns5:ComputerEquipment2024-04-012025-03-3108250302ns5:FurnitureFittings2024-03-3108250302ns5:ComputerEquipment2024-03-3108250302ns5:FurnitureFittings2025-03-3108250302ns5:ComputerEquipment2025-03-3108250302ns5:FurnitureFittings2024-03-3108250302ns5:ComputerEquipment2024-03-3108250302ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3108250302ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3108250302ns10:Director112024-03-3108250302ns10:Director112023-03-3108250302ns10:Director112024-04-012025-03-3108250302ns10:Director112023-04-012024-03-3108250302ns10:Director112025-03-3108250302ns10:Director112024-03-31
REGISTERED NUMBER: 08250302 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Sole2Heal Limited

Sole2Heal Limited (Registered number: 08250302)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Sole2Heal Limited

Company Information
for the Year Ended 31 March 2025







DIRECTOR: Mrs J Tideswell





REGISTERED OFFICE: Newby House
West Busk Lane
Otley
West Yorkshire
LS21 3LY





REGISTERED NUMBER: 08250302 (England and Wales)





ACCOUNTANTS: Blenheim Advisory Limited
Chartered Certified Accountants
3 Feast Field
Horsforth
Leeds
West Yorkshire
LS18 4TJ

Sole2Heal Limited (Registered number: 08250302)

Balance Sheet
31 March 2025

2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible assets 4 2,194 260

CURRENT ASSETS
Stocks 156 127
Debtors 5 5,814 6,926
Cash at bank 67,297 42,392
73,267 49,445
CREDITORS
Amounts falling due within one year 6 17,559 12,260
NET CURRENT ASSETS 55,708 37,185
TOTAL ASSETS LESS CURRENT
LIABILITIES

57,902

37,445

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 57,802 37,345
57,902 37,445

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Sole2Heal Limited (Registered number: 08250302)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 December 2025 and were signed by:





Mrs J Tideswell - Director


Sole2Heal Limited (Registered number: 08250302)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Sole2Heal Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Computer equipment - 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Sole2Heal Limited (Registered number: 08250302)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£ £ £
COST
At 1 April 2024 533 - 533
Additions - 2,466 2,466
At 31 March 2025 533 2,466 2,999
DEPRECIATION
At 1 April 2024 273 - 273
Charge for year 39 493 532
At 31 March 2025 312 493 805
NET BOOK VALUE
At 31 March 2025 221 1,973 2,194
At 31 March 2024 260 - 260

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Trade debtors 5,445 6,675
Other debtors 369 251
5,814 6,926

Sole2Heal Limited (Registered number: 08250302)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Trade creditors 1,180 -
Taxation and social security 7,475 6,095
Other creditors 8,904 6,165
17,559 12,260

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£ £
Mrs J Tideswell
Balance outstanding at start of year 4,606 3,157
Amounts advanced 33,149 16,055
Amounts repaid (28,850 ) (14,606 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 8,905 4,606